184 related articles for article (PubMed ID: 8679459)
1. The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.
Hollingsworth SJ; Darling D; Gäken J; Hirst W; Patel P; Kuiper M; Towner P; Humphreys S; Farzaneh F; Mufti GJ
Br J Cancer; 1996 Jul; 74(1):6-15. PubMed ID: 8679459
[TBL] [Abstract][Full Text] [Related]
2. Targeting of cytokine gene expression to malignant melanoma cells using tissue specific promoter sequences.
Vile RG; Hart IR
Ann Oncol; 1994; 5 Suppl 4():59-65. PubMed ID: 8060899
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
J Cancer Res Clin Oncol; 1994; 120(11):631-5. PubMed ID: 7962038
[TBL] [Abstract][Full Text] [Related]
4. Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice.
Lasek W; Basak G; Switaj T; Jakubowska AB; Wysocki PJ; Mackiewicz A; Drela N; Jalili A; Kamiński R; Kozar K; Jakóbisiak M
Cancer Immunol Immunother; 2004 Apr; 53(4):363-72. PubMed ID: 14605763
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.
Arienti F; Sulé-Suso J; Melani C; Maccalli C; Belli F; Illeni MT; Anichini A; Cascinelli N; Colombo MP; Parmiani G
Hum Gene Ther; 1994 Sep; 5(9):1139-50. PubMed ID: 7833372
[TBL] [Abstract][Full Text] [Related]
6. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
[TBL] [Abstract][Full Text] [Related]
7. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts.
Tsai SC; Gansbacher B; Tait L; Miller FR; Heppner GH
J Natl Cancer Inst; 1993 Apr; 85(7):546-53. PubMed ID: 8455201
[TBL] [Abstract][Full Text] [Related]
8. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
Cao X; Wang Q; Ju DW; Tao Q; Wang J
J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
[TBL] [Abstract][Full Text] [Related]
9. Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cells.
Melani C; Chiodoni C; Arienti F; Maccalli C; Sule-Suso J; Anichini A; Colombo MP; Parmiani G
Nat Immun; 1994; 13(2-3):76-84. PubMed ID: 8173238
[TBL] [Abstract][Full Text] [Related]
10. IL-2 inhibits the induction of systemic antitumour immunity by IL-4 in the peritumoural treatment of experimental melanoma.
Zaloom Y; Gallagher G
Anticancer Res; 1993; 13(4):1081-5. PubMed ID: 8352529
[TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
[TBL] [Abstract][Full Text] [Related]
12. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
[TBL] [Abstract][Full Text] [Related]
13. Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model.
Abdel-Wahab Z; Li WP; Osanto S; Darrow TL; Hessling J; Vervaert CE; Burrascano M; Barber J; Seigler HF
Cell Immunol; 1994 Nov; 159(1):26-39. PubMed ID: 7954840
[TBL] [Abstract][Full Text] [Related]
14. Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine.
Souberbielle BE; Knight BC; Morrow WJ; Darling D; Fraziano M; Marriott JB; Cookson S; Farzaneh F; Dalgleish AG
Gene Ther; 1996 Oct; 3(10):853-8. PubMed ID: 8908498
[TBL] [Abstract][Full Text] [Related]
15. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
[TBL] [Abstract][Full Text] [Related]
16. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
[TBL] [Abstract][Full Text] [Related]
17. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
[TBL] [Abstract][Full Text] [Related]
18. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF
Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.
Patel PM; Flemming CL; Russell SJ; McKay IA; MacLennan KA; Box GM; Eccles SA; Collins MK
Br J Cancer; 1993 Aug; 68(2):295-302. PubMed ID: 8347485
[TBL] [Abstract][Full Text] [Related]
20. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]